Here are five points:
1. The code is effective Jan. 1, 2017.
2. Using a minimally invasive laparoscopic procedure to place the device, the LINX intends to restore control of abnormal reflux.
3. Those procedures assigned a Category 1 Code must be consistent with contemporary medical practice, performed nationwide and supported by documented clinical evidence of efficacy.
4. Robert Ganz, MD, chief of gastroenterology at Minneapolis-based Abbott Northwestern Hospital, said, “The only option to really cure reflux is to restore sphincter competency and the LINX does that in a more natural way. I counsel patients needing an anti-reflux procedure to consider the LINX procedure first.”
5. LINX is made of interlinked titanium beads with magnetic cores.
More GI/endoscopy news:
FDA clears FUJIFILM’s new medical visualization solution: 5 things to know
Gastroenterologist to know: Dr. Seth Hoffman of Ohio Gastroenterology
EndoChoice Q3 revenue up 30%, FDA recalls Custom Ultrasonics’ automated endoscope reprocessors — 5 GI/endoscopy company key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.